Your monthly cost can vary depending on whether you have health insurance, and if Zepbound is part of your insurance plans formulary
Approved by the FDA under the name Egrifta for HIV-related lipodystrophy, it has demonstrated an increase in IGF-1, a 15.2% reduction in visceral fat, and an improvement in body composition in Phase 3 trials
Product Specifications Product Name: BPC-157 Category: Synthetic pentadecapeptide (15 amino acids) Research Classification: Investigational peptide for laboratory research Molecular Formula: CHNO Molecular Weight: Approximately 1419.5 g/mol Peptide Length: 15 amino acids Purity: 9598% (HPLC verified) Appearance: White to off-white lyophilized powder Storage (Lyophilized): 20C to 80C, protected from moisture and light Storage (Reconstituted): 4C for short-term laboratory use Compliance: Not approved by FDA or EMA
Fatigue that doesnt lift with a full nights sleep Tingling, numbness, or a pins-and-needles feeling in the hands or feet A sore, red, or unusually smooth tongue Low mood, irritability, or trouble concentrating Unsteady balance, in more advanced cases Nerve symptoms, especially tingling in the feet, can show up before a blood count looks abnormal, so fatigue alone can miss the picture